ARQ-252 Cream 0.3%

ARQ-252 · Arcutis Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARQ-252 Cream 0.3%, covering 2024-07-12 to 2024-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo [Phase 2]